Abstract:The development of efficient strategies for overcoming cancer remains a standing objective in medicinal chemistry. Design and synthesis of new potent compounds contribute efficiently to chemotherapy strategy since molecular hybridization was found an efficient strategy for designing new candidates of possible potent anticancer activities. Isoindole and 1,3,4-thiadiazole as well as glycosyl structures are known in literature with their broad-spectrum activities, the most important of which is anticancer activity. In this study, novel hybrid compounds incorporating more than motif were synthesized. A multistep synthetic pathway starting from the simple 2-amino-1,3,4-thiadiazole-2-thiol and the commercially available phthalic anhydride was applied for the preparation of the hybrid heterocyclic system. Glycosylation by acetylated glycosyl bromide and reaction with a series of monosaccharides afforded the corresponding glycosylthio-1,3,4-thiadiazole based isoindole products and the hydrazinyl-sugar derivatives, respectively. 1,3,4-Thiadiazolyl-isoindolyl-sugar compounds and related arylidenes were prepared. The cytotoxicity activity was investigated against human cancerous MCF-7 , PC-3 , A-549 and normal BJ-1 cells. The iodobutylthio-1,3,4-thiadiazolyl derivative exhibited the most potent activity against A-549 cell. The hybrid thiadiazolyl-sugar-based isoindole structure with the hydrazinyl-per- O -acetylated-D-galactose moiety exhibited the most potent activity against MCF-7 cell. Docking into epidermal growth factor (EGFR) revealed that the later bioactive compounds presented promising energy scores showing good affinity and various binding interactions into EGFR active site. In addition, Molecular dynamics (MD) simulation was performed to investigate the stability of the EGFR enzyme's binding domain applying a 100 ns simulation analysis on the docked complex of EGFR with the potent compound 10 which showed that the sugar hydrazone 10 remained in the EGFR binding cavity over the 100 ns simulation with different orientations.

Synthesis and Evaluation of Thiazolyl-indole-2-carboxamide Derivatives as Potent Multitarget Anticancer Agents

Synthesis, Molecular Docking and Antitumor Activity of New Dithiazoles

New Indazol-Pyrimidine-Based Derivatives as Selective Anticancer Agents: Design, Synthesis, and In Silico Studies

Synthesis, Antiproliferative Evaluation, and Molecular Docking of Thieno[3,2-e]indazole Derivatives

Design, synthesis, and in vitro and in vivo biological evaluation of triazolopyrimidine hybrids as multitarget directed anticancer agents

Synthesis Of Some Novel Thiophene Analogues As Potential Anticancer Agents

Synthesis, In Vitro Evaluation and Molecular Docking Studies of Novel Thiophenyl Thiazolyl-Pyridine Hybrids as Potential Anticancer Agents

Synthesis and molecular docking of some new thiazolidinone and thiadiazole derivatives as anticancer agents

Synthesis and biological evaluation of novel 2-morpholino-4-anilinoquinoline derivatives as antitumor agents against HepG2 cell line

Design, Synthesis, Cytotoxic Screening and Molecular Docking Studies of Novel Hybrid Thiosemicarbazone Derivatives as Anticancer Agents

Synthesis and Biological Evaluation of Novel Pyrazoline Derivatives Containing Indole Skeleton As Anti-Cancer Agents Targeting Topoisomerase II.

Novel quinazolines bearing 1,3,4-thiadiazole-aryl urea derivative as anticancer agents: design, synthesis, molecular docking, DFT and bioactivity evaluations

Design, Synthesis, and Docking Simulation of 1,3,4-Thiadiazolyl-Isoindole Thioglycosides and Hydrazinyl Sugar Analogs as Potential Anticancer Agents Targeting EGFR Kinase

In the pursuit of novel therapeutic agents: synthesis, anticancer evaluation, and physicochemical insights of novel pyrimidine-based 2-aminobenzothiazole derivatives

Synthesis, Characterization, and Biological Evaluation of Some Novel Pyrazolo[5,1-b]thiazole Derivatives as Potential Antimicrobial and Anticancer Agents

Design, Synthesis, and In Vitro Cytotoxic Studies of Some Novel Arylidene-Hydrazinyl-Thiazoles as Anticancer and Apoptosis-Inducing Agents

Design, synthesis, and docking of novel thiazolidine-2,4-dione multitarget scaffold as new approach for cancer treatment

Synthesis, molecular modelling and biological significance of N-(4-(4-bromophenyl) thiazol-2-yl)-2-chloroacetamide derivatives as prospective antimicrobial and antiproliferative agents

Design, Synthesis, and Biological Evaluation of Newly Synthesized Cinnamide-Fluorinated Containing Compounds as Bioactive Anticancer Agents

Synthesis, Molecular Docking Studies and In Silico ADMET Screening of New Heterocycles Linked Thiazole Conjugates as Potent Anti-Hepatic Cancer Agents

Novel 1,2,3-Triazole-Coumarin Hybrid Glycosides and Their Tetrazolyl Analogues: Design, Anticancer Evaluation and Molecular Docking Targeting EGFR, VEGFR-2 and CDK-2